A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy
- PMID: 11027423
- PMCID: PMC2363577
- DOI: 10.1054/bjoc.2000.1425
A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy
Abstract
One hundred and seventy-five children with Stage 3 or 4 neuroblastoma who had obtained a good response to conventional therapy were randomly allocated to 13-Cis retinoic acid at a dose of 0.75 mg/kg/day or placebo for up to 4 years. Toxicity was mild but no advantage in event-free survival was shown for the children receiving retinoic acid.
Copyright 2000 Cancer Research Campaign.
Similar articles
-
Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.Nuklearmedizin. 2006;45(4):145-51; quiz N39-40. Nuklearmedizin. 2006. PMID: 16964339
-
13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group.Med Pediatr Oncol. 1992;20(4):307-11. doi: 10.1002/mpo.2950200407. Med Pediatr Oncol. 1992. PMID: 1608352
-
Does megatherapy contribute to survival in metastatic neuroblastoma? A retrospective analysis. German Cooperative Neuroblastoma Study Group.Klin Padiatr. 1997 Jul-Aug;209(4):196-200. doi: 10.1055/s-2008-1043950. Klin Padiatr. 1997. PMID: 9293450
-
Retinoic Acid for High-risk Neuroblastoma Patients after Autologous Stem Cell Transplantation - Cochrane Review.Klin Padiatr. 2016 Apr;228(3):124-9. doi: 10.1055/s-0042-101169. Epub 2016 Mar 24. Klin Padiatr. 2016. PMID: 27011226 Review. English.
-
Evidence for the efficacy of immunotherapy in children with high-risk neuroblastoma.Postepy Hig Med Dosw (Online). 2016 Sep 28;70(0):1001-1004. doi: 10.5604/17322693.1220380. Postepy Hig Med Dosw (Online). 2016. PMID: 27708204 Review.
Cited by
-
Differentiating Neuroblastoma: A Systematic Review of the Retinoic Acid, Its Derivatives, and Synergistic Interactions.J Pers Med. 2021 Mar 16;11(3):211. doi: 10.3390/jpm11030211. J Pers Med. 2021. PMID: 33809565 Free PMC article. Review.
-
Neuroblastoma: evolving therapies for a disease with many faces.Paediatr Drugs. 2004;6(2):107-22. doi: 10.2165/00148581-200406020-00004. Paediatr Drugs. 2004. PMID: 15035651 Review.
-
Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma - a study of the United Kingdom Children's Cancer Study Group.Br J Cancer. 2007 Feb 12;96(3):424-31. doi: 10.1038/sj.bjc.6603554. Epub 2007 Jan 16. Br J Cancer. 2007. PMID: 17224928 Free PMC article.
-
Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects.Cancers (Basel). 2024 Jan 26;16(3):544. doi: 10.3390/cancers16030544. Cancers (Basel). 2024. PMID: 38339295 Free PMC article. Review.
-
Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients.Pediatr Surg Int. 2007 Jul;23(7):637-46. doi: 10.1007/s00383-007-1933-7. Epub 2007 May 3. Pediatr Surg Int. 2007. PMID: 17476512
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical